Leptin Decreases Gluconeogenesis and Gluconeogenic Substrate Availability in Patients With Lipodystrophy

被引:0
|
作者
Quaye, Emmanuel [1 ]
Chacko, Shaji [2 ]
Startzell, Megan [1 ]
Brown, Rebecca J. [1 ]
机构
[1] NIDDK, NIH, Bldg 10-CRC,Room 6-5942,10 Ctr Dr, Bethesda, MD 20892 USA
[2] USDA ARS, Childrens Nutr Res Ctr, Dept Pediat, Baylor Coll Med, Houston, TX 77030 USA
来源
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2023年 / 109卷 / 01期
关键词
gluconeogenesis; lipodystrophy; leptin; lipolysis; alanine; lactate; INSULIN SENSITIVITY; GLUCOSE-PRODUCTION; ENERGY; METRELEPTIN; METABOLISM; HORMONE;
D O I
10.1210/clinem/dgad445
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context The effects of leptin, an adipocyte-derived hormone that signals overall energy sufficiency, can only be studied in leptin-deficient conditions. In patients with lipodystrophy, a rare disease and unique model of leptin deficiency, treatment with recombinant leptin (metreleptin) improves glycemia and decreases energy expenditure. We hypothesized that these improvements might be mediated by reduced gluconeogenesis (GNG), an energy-requiring process.Objective To determine the effects of metreleptin on GNG and GNG substrates.Methods This was a single-arm prospective study of metreleptin administration in 15 patients with lipodystrophy, 9 of whom had data on GNG (NIH, 2013-2018). We analyzed total GNG, insulin-mediated suppression of GNG, glycerol, palmitate, alanine, lactate, peripheral and hepatic insulin sensitivity, and markers of glycemia (eg, HbA1c, glucose, fasting insulin).Results Metreleptin administration decreased basal GNG, increased insulin-mediated suppression of GNG, and improved insulin sensitivity and markers of glycemic control. Metreleptin reduced carbon sources for GNG, including plasma alanine and lactate, and rate of appearance (Ra) of glycerol, and decreased Ra of palmitate, a driver of GNG. Glycerol and palmitate Ra correlated with GNG prior to but not during metreleptin administration. Alanine strongly correlated with GNG both before and during metreleptin administration.Conclusions Metreleptin treatment in patients with lipodystrophy reduced GNG likely through decreased availability of carbon sources for gluconeogenesis, such as alanine, lactate, and glycerol. Associations between alanine and GNG persisted after metreleptin treatment while correlations with glycerol and palmitate Ra did not persist, suggesting reduced importance of lipolysis as a driver of GNG in the leptin-replete state.
引用
收藏
页码:e209 / e215
页数:7
相关论文
共 50 条
  • [1] Leptin Decreases Gluconeogenesis and Gluconeogenic Substrate Availability in Patients With Lipodystrophy
    Quaye, Emmanuel
    Chacko, Shaji
    Startzell, Megan
    Brown, Rebecca J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (01): : e209 - e215
  • [2] Leptin decreases de novo lipogenesis in patients with lipodystrophy
    Baykal, Annah P.
    Parks, Elizabeth J.
    Shamburek, Robert
    Syed-Abdul, Majid M.
    Chacko, Shaji
    Cochran, Elaine
    Startzell, Megan
    Gharib, Ahmed M.
    Ouwerkerk, Ronald
    Abd-Elmoniem, Khaled Z.
    Walter, Peter J.
    Walter, Mary
    Muniyappa, Ranganath
    Chung, Stephanie T.
    Brown, Rebecca J.
    JCI INSIGHT, 2020, 5 (14)
  • [3] Leptin Decreases Energy Expenditure Despite Increased Thyroid Hormone in Patients With Lipodystrophy
    Grover, Andrew
    Quaye, Emmanuel
    Brychta, Robert J.
    Christensen, John
    Startzell, Megan S.
    Meehan, Cristina Adelia
    Valencia, Areli
    Marshall, Brandon
    Chen, Kong Y.
    Brown, Rebecca J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (10): : E4163 - E4178
  • [4] EFFECT OF DICHLOROACETATE ON GLUCONEOGENESIS INVIVO IN THE PRESENCE OF A FIXED GLUCONEOGENIC SUBSTRATE SUPPLY TO THE LIVER
    DIAMOND, MP
    WILLIAMS, PE
    LACY, WW
    CHERRINGTON, AD
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1981, 30 (09): : 880 - 885
  • [5] HEPATIC GLUCONEOGENIC HYPERSENSITIVITY TO SUBSTRATE AVAILABILITY IN TYPE-II DIABETES
    TOFT, I
    BURHOL, PG
    NURJHAN, N
    GERICH, JE
    JENSSEN, TG
    DIABETOLOGIA, 1992, 35 : A106 - A106
  • [6] Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency
    McDuffie, JR
    Riggs, PA
    Calis, KA
    Freedman, RJ
    Oral, EA
    DePaoli, AM
    Yanovski, JA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09): : 4258 - 4263
  • [7] Recombinant leptin reverses nonalcoholic steatohepatitis in patients with lipodystrophy
    Javor, ED
    Ghany, MG
    Cochran, EK
    Oral, EA
    Depaoli, AM
    Kleiner, DE
    Gorden, P
    DIABETES, 2004, 53 : A363 - A363
  • [8] Leptin Attenuates Cardiac Hypertrophy in Patients With Generalized Lipodystrophy
    My-Le Nguyen
    Sachdev, Vandana
    Burklow, Thomas R.
    Li, Wen
    Startzell, Megan
    Auh, Sungyoung
    Brown, Rebecca J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (11): : E4327 - E4339
  • [9] Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy
    Javor, ED
    Ghany, MG
    Cochran, EK
    Oral, EA
    DePaoli, AM
    Premkumar, A
    Kleiner, DE
    Gorden, P
    HEPATOLOGY, 2005, 41 (04) : 753 - 760
  • [10] Effects of Leptin on Regulators of Lipoprotein Lipase in Patients with Lipodystrophy
    Lightbourne, Marissa
    Abel, Brent
    Walter, Mary
    Shamburek, Robert
    Muniyappa, Ranganath
    Brown, Rebecca J.
    DIABETES, 2017, 66 : A60 - A60